본문 바로가기

Exploring the prescribing trends and factors affecting initial anti-parkinsonian drug selection in Korea: A nationwide population-based cohort study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q1
저널
JOURNAL OF CLINICAL NEUROSCIENCE116 · pp.60 · 2023
피인용
Web of Science 1Scopus 1
FWCI (Scopus)
0
JCR IF
JCR 2022 2
ISSN
0967-5868

저자

  1. 구민희제1저자Pusan Natl Univ, Coll Pharm, Busan, South Korea
  2. 제남경교신저자Pusan Natl Univ, Coll Pharm, Busan, South Korea

초록

Background: Parkinson's disease (PD) is a common neurodegenerative disorder typically treated with dopamine replacement therapy and dopamine agonists (DAs) to alleviate symptoms and minimize dyskinesia. Optimal treatment strategies for patients newly diagnosed with PD have been a topic of debate for many years. Methods: We conducted a 10-year descriptive study of drug prescription trends and factors affecting prescription choices for newly diagnosed drug-naive PD patients using data from the National Health Insurance program in Korea. To identify statistically significant differences in yearly trends, we employed the Cochran-Armitage trend test. Additionally, we utilized multiple logistic regression analysis to investigate the factors associated with the selection of levodopa and DAs as initial anti-parkinsonian drugs. Results: A total of 99,118 patients with PD who were prescribed levodopa or DAs alone as initial antiparkinsonian drugs between 2011 and 2020 were eligible for inclusion in the analysis. The prescription rate of DAs increased until 2012, and then steadily decreased annually. The likelihood of levodopa prescription increased with age and at higher-level hospitals. In terms of comorbidities, patients with Alzheimer's disease and cerebrovascular diseases were more likely to be prescribed levodopa than those with peptic ulcer disease and dyslipidemia. Conclusion: The decline in levodopa prescriptions was reversed in 2012, and the prescription rate has continued to increase until recently. The odds ratio of levodopa prescription increased in elderly patients with Alzheimer's disease and decreased in patients with Medical aid insurance and peptic ulcer disease.

키워드

Anti-parkinsonian drugDopamine agonistLevodopaGENDER-DIFFERENCESDOPAMINE AGONISTSDOUBLE-BLINDDISEASELEVODOPAPRAMIPEXOLEEPIDEMIOLOGYFLUCTUATIONSDYSKINESIAMANAGEMENT

식별자

Scopus EID
2-s2.0-85168714764
WoS UID
001066939900001